Eric Pauwels
CIK 1323212 · CHIEF BUSINESS OFFICER · last filed 2026-02-20
Eric Pauwels is a CHIEF BUSINESS OFFICER who has filed 47 SEC Form 4 insider transactions across 3 companies since 2011. The most recent filing shows the insider sold $209.4K of PTCT on Feb 20, 2026. Across all open-market trades the lifetime net is −$11.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.81M
3
47
-$11.03M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PTCT | CHIEF BUSINESS OFFICER | 77,122 | $75.14 | $5.79M | -$11.03M | 35 | 2026-02-20 |
| NPS PHARMACEUTICALS INC (NPSP) Delisted | President, NPS Pharma Int'l | 0 | — | — | $0 | 11 | 2015-02-24 |
| ARAY | SVP Chief Marketing Officer | 30,000 | $0.34 | $10.2K | $0 | 1 | 2011-03-01 |
Recent Filings
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-20 | PTCT | Sell (S) | −3,019 | -$209.4K | EDGAR |
| 2026-01-12 | PTCT | Sell (S) | −7,348 | -$565.9K | EDGAR |
| 2026-01-08 | PTCT | Sell (S) | −3,141 | -$242.4K | EDGAR |
| 2026-01-06 | PTCT | Grant (A) | +20,000 | $0 | EDGAR |
| 2025-12-23 | PTCT | Mixed | — | -$248.2K | EDGAR |
| 2025-12-19 | PTCT | Mixed | +100 | -$570.7K | EDGAR |
| 2025-09-09 | PTCT | Mixed | — | -$1.36M | EDGAR |
| 2025-03-18 | PTCT | Sell (S) | −11,220 | -$630.1K | EDGAR |
| 2025-02-21 | PTCT | Sell (S) | −2,945 | -$147.6K | EDGAR |
| 2025-01-10 | PTCT | Sell (S) | −3,735 | -$167.6K | EDGAR |